Chemoinformaics analysis of (-)-3ALPHA,6BETA-DITIGLOYLOXYTROPANE
| Molecular Weight | 321.417 | nRot | 4 |
| Heavy Atom Molecular Weight | 294.201 | nRig | 13 |
| Exact Molecular Weight | 321.194 | nRing | 2 |
| Solubility: LogS | -2.483 | nHRing | 2 |
| Solubility: LogP | 2.295 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 27 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 52.3714 |
| nHD | 0 | BPOL | 34.0046 |
| QED | 0.588 |
| Synth | 4.931 |
| Natural Product Likeliness | 2.125 |
| NR-PPAR-gamma | 0.011 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.929 |
| Pgp-sub | 0.003 |
| HIA | 0.008 |
| CACO-2 | -4.562 |
| MDCK | 0.0000227 |
| BBB | 0.374 |
| PPB | 0.473558 |
| VDSS | 3.02 |
| FU | 0.383852 |
| CYP1A2-inh | 0.029 |
| CYP1A2-sub | 0.177 |
| CYP2c19-inh | 0.176 |
| CYP2c19-sub | 0.913 |
| CYP2c9-inh | 0.122 |
| CYP2c9-sub | 0.376 |
| CYP2d6-inh | 0.967 |
| CYP2d6-sub | 0.787 |
| CYP3a4-inh | 0.845 |
| CYP3a4-sub | 0.821 |
| CL | 12.662 |
| T12 | 0.672 |
| hERG | 0.152 |
| Ames | 0.011 |
| ROA | 0.112 |
| SkinSen | 0.925 |
| Carcinogencity | 0.084 |
| EI | 0.028 |
| Respiratory | 0.827 |
| NR-Aromatase | 0.001 |
| Antiviral | Yes |
| Prediction | 0.862752 |